Cardiol Therapeutics, Inc. (CRDL)
2.29
+0.07
(+3.15%)
USD |
NASDAQ |
Sep 09, 16:00
2.29
0.00 (0.00%)
After-Hours: 16:07
Cardiol Therapeutics Shareholders Equity (Quarterly) : 16.94M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 16.94M |
| March 31, 2026 | 17.34M |
| December 31, 2025 | 13.04M |
| September 30, 2025 | 6.871M |
| June 30, 2025 | 8.654M |
| March 31, 2025 | 12.22M |
| December 31, 2024 | 17.19M |
| September 30, 2024 | 7.722M |
| June 30, 2024 | 11.23M |
| March 31, 2024 | 14.82M |
| December 31, 2023 | 21.42M |
| September 30, 2023 | 25.79M |
| June 30, 2023 | 29.28M |
| March 31, 2023 | 33.66M |
| December 31, 2022 | 38.53M |
| September 30, 2022 | 42.70M |
| June 30, 2022 | 48.72M |
| March 31, 2022 | 55.41M |
| Date | Value |
|---|---|
| December 31, 2021 | 60.36M |
| September 30, 2021 | 22.96M |
| June 30, 2021 | 27.24M |
| March 31, 2021 | 14.51M |
| December 31, 2020 | 10.42M |
| September 30, 2020 | 16.82M |
| June 30, 2020 | 19.17M |
| March 31, 2020 | 8.800M |
| December 31, 2019 | 11.31M |
| September 30, 2019 | 12.57M |
| June 30, 2019 | 14.99M |
| March 31, 2019 | 16.42M |
| December 31, 2018 | 16.31M |
| September 30, 2018 | -0.7444M |
| June 30, 2018 | 0.7029M |
| March 31, 2018 | |
| December 31, 2017 | 2.278M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| InMed Pharmaceuticals, Inc. | 6.892M |
| NervGen Pharma Corp. | 12.18M |
| Milestone Pharmaceuticals, Inc. | 18.22M |
| Clearmind Medicine, Inc. | 11.49M |
| Lexaria Bioscience Corp. | 4.738M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 20.69M |
| Total Liabilities (Quarterly) | 3.756M |
| Debt to Equity Ratio | 0.0045 |
| Current Ratio | 5.553 |
| Net Debt Paydown Yield | 0.00% |